FindTrial
Sign In

Study to check the safety and efficacy of cosmetic product

The objective of this study will be to evaluate and compare the in-vivo safety and efficacy of skin care formulation versus Untreated control in terms of the skin moisturization and transepidermal water loss on healthy human participants - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113999
Enrollment
30
Registered
2026-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: Twenty microliters of the test product will be applied to one randomized site measuring three by three square centimeters on each right forearm, left forearm, and area aro

Sponsors

Bajaj Consumer Care Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Indian or Asian female subjects 2.Healthy subjects 3.Skin is healthy on the studied anatomic unit 4.Participant having dry skin type.

Exclusion criteria

Exclusion criteria: 1.Being pregnant or breastfeeding or having 2.stopped breastfeeding within the past three months 3.Refusing to provide assent by not signing the informed consent form 4.Taking part in another study that may interfere with this study 5.Being insulin dependent diabetic or non insulin dependent diabetic with recent therapy within the past six months 6.Having progressive asthma either under treatment or with an asthma attack within the past two years 7.Having a chronic skin disease that may modify skin reactivity in the test area except in studies specifically conducted on that skin disease 8.Having unstable thyroid disease requiring treatment that has not been stable for at least six months 9.Being diagnosed with epilepsy 10.Receiving chronic medicinal treatment including aspirin based products anti inflammatory drugs antihistamines or corticosteroids administered by either general or local routes The only permitted medication is paracetamol 11.Having skin hypersensitivity 12.Having a diagnosed or highly probable allergy to one or more ingredients of the cosmetic products 13.Having undergone surgery requiring general anesthesia for more than one hour within the past six months

Design outcomes

Primary

MeasureTime frame
skin moisturization and transepidermal water lossTimepoint: Baseline, 15 minutes, 30 minutes, 24 Hours, 48 Hours, 72 hours after product application—

Secondary

MeasureTime frame
Skin glow, skin smoothness and skin elasticityTimepoint: Baseline, 15 minutes, 30 minutes, 24 Hours, 48 Hours, 72 hours after product application—

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

niharika@mascotspincontrol.in08657063276

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026